FDG-PET as a predictive biomarker for therapy with everolimus in metastatic renal cell cancer.

Cancer Med · 2013 · PMC3799289 · PMID 24156027

Europe PMC DOI

hedged sentence

0.1400

closest p · 2.8× alpha

0.1400

boldest claim

The sentences

a trend toward significanceP = 0.14not close (p > 0.1)

Although a trend toward significance was noted for OS, this effect disappeared when we examined only the clear cell subtype (HR = 3.0; P = 0.14) ( Fig. 3 ).

also in 3,729 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.